
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of Japanese policies and novel hypnotics on long‐term prescriptions of hypnotics
Masahiro Takeshima, Kazuhisa Yoshizawa, Minori Enomoto, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 5, pp. 264-272
Open Access | Times Cited: 13
Masahiro Takeshima, Kazuhisa Yoshizawa, Minori Enomoto, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 5, pp. 264-272
Open Access | Times Cited: 13
Showing 13 citing articles:
Treatment strategy for insomnia disorder: Japanese expert consensus
Yoshikazu Takaesu, Hitoshi Sakurai, Yumi Aoki, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 16
Yoshikazu Takaesu, Hitoshi Sakurai, Yumi Aoki, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 16
Treatment Failure and Long-Term Prescription Risk for Guideline-Recommended Hypnotics in Japan
Masahiro Takeshima, Kazuhisa Yoshizawa, Masaya Ogasawara, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246865-e246865
Open Access | Times Cited: 4
Masahiro Takeshima, Kazuhisa Yoshizawa, Masaya Ogasawara, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246865-e246865
Open Access | Times Cited: 4
Efficacy and safety of each class of sleep medication for major depressive disorder with insomnia symptoms: A systematic review and meta‐analysis of double‐blind randomized controlled trials
Taku Maruki, Masahiro Takeshima, Kazuhisa Yoshizawa, et al.
Psychiatry and Clinical Neurosciences (2025)
Open Access
Taku Maruki, Masahiro Takeshima, Kazuhisa Yoshizawa, et al.
Psychiatry and Clinical Neurosciences (2025)
Open Access
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
Naomi Hasegawa, Yuka Yasuda, Norio Yasui‐Furukori, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 10, pp. 559-568
Open Access | Times Cited: 9
Naomi Hasegawa, Yuka Yasuda, Norio Yasui‐Furukori, et al.
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 10, pp. 559-568
Open Access | Times Cited: 9
Parasomnia induced by lemborexant: a case report
Toshinori Nakamura, Yusuke Arai, Tetsuya Hagiwara, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 3
Toshinori Nakamura, Yusuke Arai, Tetsuya Hagiwara, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 3
Treatment strategies for insomnia in Japanese primary care physicians’ practice: A Web-based questionnaire survey
Masahiro Takeshima, Hitoshi Sakurai, Ken Inada, et al.
BMC Primary Care (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Masahiro Takeshima, Hitoshi Sakurai, Ken Inada, et al.
BMC Primary Care (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Association between benzodiazepine anxiolytic polypharmacy and concomitant psychotropic medications in Japan: a retrospective cross-sectional study
Masahiro Takeshima, Kazuhisa Yoshizawa, Masaya Ogasawara, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Masahiro Takeshima, Kazuhisa Yoshizawa, Masaya Ogasawara, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Psychosocial characteristics of the general population who habitually use hypnotics: Results from a national survey on drug use among the Japanese
Satomi Mizuno, Takuya Shimane, Satoshi Inoura, et al.
Psychiatry and Clinical Neurosciences Reports (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Satomi Mizuno, Takuya Shimane, Satoshi Inoura, et al.
Psychiatry and Clinical Neurosciences Reports (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation: A Cross-Sectional Survey in Japan
Yumi Aoki, Masahiro Takeshima, Takashi Tsuboi, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 7, pp. 5373-5373
Open Access | Times Cited: 2
Yumi Aoki, Masahiro Takeshima, Takashi Tsuboi, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 7, pp. 5373-5373
Open Access | Times Cited: 2
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
Toshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
Association between polypharmacy and the long-term prescription of hypnotics in Japan: a retrospective cross-sectional study
Munehiro Komatsu, Masahiro Takeshima, Kazuhisa Yoshizawa, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Munehiro Komatsu, Masahiro Takeshima, Kazuhisa Yoshizawa, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Legislation alone is not enough to reduce prescriptions of benzodiazepines
Takashi Tsuboi
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 5, pp. 251-251
Closed Access
Takashi Tsuboi
Psychiatry and Clinical Neurosciences (2023) Vol. 77, Iss. 5, pp. 251-251
Closed Access
Prescription patterns of psychotropics for adults treated with ADHD medications: Analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) of 2019
Kanako Ishizuka
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 3
Open Access
Kanako Ishizuka
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 3
Open Access